Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?

J Clin Oncol. 1995 Apr;13(4):1044-5. doi: 10.1200/JCO.1995.13.4.1044.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Lymph Nodes / pathology*
  • Postmenopause*
  • Receptors, Estrogen / metabolism*

Substances

  • Receptors, Estrogen